Comparing the Efficiency of Three Third-generation Supraglottic Airways as an Intubation Route
NCT ID: NCT02975466
Last Updated: 2018-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2017-03-21
2018-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
I-gel vs AuraGain for Bronchoscopic Intubation Through SGA
NCT04680169
Comparison of Endotracheal Intubation Over the Aintree Via the I-gel and Laryngeal Mask Airway Supreme
NCT02476565
A RCT on Supraglottic Airway Versus Endotracheal Intubation in OHCA
NCT02967952
Three Different Techniques for Tracheal Intubation Via Supraglottic Airway Devices
NCT04346459
Ambu Aura-i Laryngeal Mask Versus Air-Q Intubating Laryngeal Airway for Tracheal Intubation in Adults
NCT02226211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AirQ Blocker supra-glottic airway device
Group of patients in which the Air-Q Blocker will be used and measured as an intubation conduit.
Insertion of AirQ Blocker and intubation through the device
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
AuraGain supra-glottic airway device
Group of patients in which the AuraGain will be used and measured as an intubation conduit.
Insertion of AuraGain and intubation through the device
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
I-Gel supra-glottic airway device
Group of patients in which the I-Gel will be used and measured as an intubation conduit.
Insertion of I-Gel and intubation through the device
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insertion of AirQ Blocker and intubation through the device
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Insertion of AuraGain and intubation through the device
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Insertion of I-Gel and intubation through the device
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA score of 1-3
* Elective or urgent surgery planned to last at least 30 minutes under general anesthesia with endotracheal intubation
Exclusion Criteria
* Any contraindication to the drugs planned by the trial
* Pregnancy
* Severe or uncontrolled obstructive pulmonary disease
* Significant cervical spine anomaly
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie-Josee Colas
Anesthesiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-José Colas, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Talaat AH, Mostafa AEE, Mohsen ME, Hesham SA. Comparative study between Air-Q and Intubating Laryngeal Mask Airway when used as conduit for fiber-optic. Egyptian Journal of Anaesthesia 30(2), 2013
Apfelbaum JL, Hagberg CA, Caplan RA, Blitt CD, Connis RT, Nickinovich DG, Hagberg CA, Caplan RA, Benumof JL, Berry FA, Blitt CD, Bode RH, Cheney FW, Connis RT, Guidry OF, Nickinovich DG, Ovassapian A; American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology. 2013 Feb;118(2):251-70. doi: 10.1097/ALN.0b013e31827773b2. No abstract available.
Laferriere-Langlois P, Dion A, Guimond E, Nadeau F, Gagnon V, D'Aragon F, Sansoucy Y, Colas MJ. A randomized controlled trial comparing three supraglottic airway devices used as a conduit to facilitate tracheal intubation with flexible bronchoscopy. Can J Anaesth. 2023 May;70(5):851-860. doi: 10.1007/s12630-023-02444-z. Epub 2023 Apr 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-1484
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.